386 related articles for article (PubMed ID: 22940848)
1. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
[TBL] [Abstract][Full Text] [Related]
2. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H
Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.
Tanis E; Nordlinger B; Mauer M; Sorbye H; van Coevorden F; Gruenberger T; Schlag PM; Punt CJ; Ledermann J; Ruers TJ
Eur J Cancer; 2014 Mar; 50(5):912-9. PubMed ID: 24411080
[TBL] [Abstract][Full Text] [Related]
4. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
[TBL] [Abstract][Full Text] [Related]
5. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.
Abdalla EK; Vauthey JN; Ellis LM; Ellis V; Pollock R; Broglio KR; Hess K; Curley SA
Ann Surg; 2004 Jun; 239(6):818-25; discussion 825-7. PubMed ID: 15166961
[TBL] [Abstract][Full Text] [Related]
6. FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases.
Beppu T; Hayashi N; Masuda T; Komori H; Horino K; Hayashi H; Okabe H; Baba Y; Kinoshita K; Akira C; Watanebe M; Takamori H; Baba H
Anticancer Res; 2010 Mar; 30(3):1015-20. PubMed ID: 20393029
[TBL] [Abstract][Full Text] [Related]
7. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Pozzo C; Cassano A; Giovannini I; Barone C
J Gastrointest Surg; 2007 Mar; 11(3):318-24. PubMed ID: 17458605
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases.
Nielsen K; Scheffer HJ; Volders JH; van der Vorst MJ; van Tilborg AA; Comans EF; de Lange-de Klerk ES; Sietses C; Meijer S; Meijerink MR; van den Tol MP
World J Surg; 2016 Aug; 40(8):1951-8. PubMed ID: 27220509
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.
He N; Jin QN; Wang D; Yang YM; Liu YL; Wang GB; Tao KX
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):514-518. PubMed ID: 27465325
[TBL] [Abstract][Full Text] [Related]
10. Treatment of colorectal cancer with unresectable synchronous liver-only metastases with combined therapeutic modalities.
Cui Y; Li H; Wu Q; Zhang T; Kong D; Song T; Ru T; Chen P; Li Q
J Gastrointest Surg; 2011 Feb; 15(2):285-93. PubMed ID: 20922574
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
12. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases.
Lam VW; Spiro C; Laurence JM; Johnston E; Hollands MJ; Pleass HC; Richardson AJ
Ann Surg Oncol; 2012 Apr; 19(4):1292-301. PubMed ID: 21922338
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
16. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
17. Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases.
Scoggins CR; Campbell ML; Landry CS; Slomiany BA; Woodall CE; McMasters KM; Martin RC
Ann Surg Oncol; 2009 Jan; 16(1):35-41. PubMed ID: 18987915
[TBL] [Abstract][Full Text] [Related]
18. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
Pak LM; Kemeny NE; Capanu M; Chou JF; Boucher T; Cercek A; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
[TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
20. Solitary colorectal liver metastasis: resection determines outcome.
Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
